High materiality7/10
Ionis Pharmaceuticals price target lowered to $104 from $110 at Morgan Stanley
Why it may matterVerify against the original reporting
Bearish setup from downgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley cuts PT to $104; current price around $56.70; downgrade.
- PT cut to $104; price 56.70
Key facts
- 01
Target: $104
- 02
Posted price: $56.7
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Michael Ulz
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.